DXCM logo DexCom +
DexCom
+

DexCom (DXCM) Business News

Track DexCom in real time with a live news feed covering DexCom stock news, official press releases, company announcements, and an archive of historical DexCom news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

96,427 Shares of DexCom, Inc. $DXCM Bought by HWG Holdings LP

Defense World

7:13 AM | Thursday | Oct 8, 2026

news photo
Loading...

HWG Holdings LP acquired a new stake in shares of DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 96,427 shares of the medical device company's stock, valued at approximately $8,321,000. DexCom makes up approximately 1.9% of HWG

Read full article redirect
7:13 AM | Thursday | Oct 8, 2026

96,427 Shares of DexCom, Inc. $DXCM Bought by HWG Holdings LP

Defense World

HWG Holdings LP acquired a new stake in shares of DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 96,427 shares of the medical device company's stock, valued at approximately $8,321,000. DexCom makes up approximately 1.9% of HWG

Read full article arrow
News Thumbnail
7:13 AM | Thursday | Oct 8, 2026

96,427 Shares of DexCom, Inc. $DXCM Bought by HWG Holdings LP

Defense World

HWG Holdings LP acquired a new stake in shares of DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 96,427 shares of the medical device company's stock, valued at approximately $8,321,000. DexCom makes up approximately 1.9% of HWG

Read full article arrow
News Thumbnail
9:00 AM | Tuesday | Oct 6, 2026

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

Business Wire

SAN DIEGO--(BUSINESS WIRE)--DEXCOM, INC. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fifth season of Dexcom U, the company's one-of-a-kind NIL (Name, Image and Likeness) program exclusively for college athletes with diabetes.Now in its fifth year, this marks the program's largest and most expansive roster to date, featuring 27 college athletes, 12 new and 15 returning, across 13 sports. The expansion is backed by new research showing that programs l.

Read full article arrow
News Thumbnail
12:00 PM | Friday | Oct 2, 2026

DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care

Zacks Investment Research

Dexcom sees room to expand CGM adoption as low awareness, reimbursement hurdles and rising GLP-1 use create new opportunities in Type 2 diabetes.

Read full article arrow
News Thumbnail
10:46 AM | Tuesday | Sep 29, 2026

Here's Why DexCom (DXCM) is a Strong Growth Stock

Zacks Investment Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read full article arrow
News Thumbnail
3:00 AM | Monday | Sep 28, 2026

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

GuruFocus

[url="]DexCom, Inc.[/url] (NASDAQ: DXCM), the global leader in glucose biosensing, today released its “Dexcom State of Type 2 Report: Global Access and Attitu

Read full article arrow
News Thumbnail
2:00 AM | Monday | Sep 28, 2026

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

Business Wire

MILAN--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today released its “Dexcom State of Type 2 Report: Global Access and Attitudes to Diabetes Technology” in advance of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28-Oct. 2. The company also announced a partnership to become the official continuous glucose monitor of Team Novo Nordisk.
Dexcom releases 2026 edition of its State of Type 2 Repo.

Read full article arrow
News Thumbnail
4:15 AM | Friday | Sep 25, 2026

DexCom, Inc. (NASDAQ:DXCM) Stock Rated “Moderate Buy” by Wall Street Brokerages

Defense World

DexCom, Inc. (NASDAQ: DXCM - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twenty-six ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, twenty-one have issued a buy rating and two have

Read full article arrow
News Thumbnail
2:26 PM | Tuesday | Sep 22, 2026

Oura's $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring

MarketBeat

Oura Inc. NASDAQ: OURA launched its roadshow on Sept. 21, 2026, targeting a Nasdaq debut under the ticker OURA during the week of Sept.

Read full article arrow
News Thumbnail
4:30 PM | Monday | Sep 14, 2026

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

Business Wire

SAN DIEGO--(BUSINESS WIRE)--Dexcom Promotes Jereme Sylvain to Chief Operating Officer.

Read full article arrow
News Thumbnail
4:21 PM | Monday | Sep 14, 2026

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

Zacks Investment Research

DXCM's strong growth, G7 15 Day adoption and CONNECT trial could expand its CGM market opportunity despite reimbursement and competition risks.

Read full article arrow
News Thumbnail